SLP
Simulations Plus IncNASDAQHEALTHCAREHEALTH INFORMATION SERVICES
Key Statistics
Market Cap
$306.11M
P/E Ratio
—
EPS
$-3.17
Beta
1.28
52W High
$34.01
52W Low
$11.09
50-Day MA
$12.84
200-Day MA
$15.38
Dividend Yield
—
Profit Margin
-78.00%
Forward P/E
21.64
PEG Ratio
9.88
About Simulations Plus Inc
Simulations Plus, Inc. develops drug discovery and development software for mechanistic modeling, simulation, and prediction of molecule properties using artificial intelligence and machine learning technology worldwide. The company is headquartered in Lancaster, California.
Fundamentals
| Revenue (TTM) | $80.53M |
| Gross Profit (TTM) | $49.91M |
| EBITDA | $13.96M |
| Operating Margin | 23.20% |
| Return on Equity | -38.80% |
| Return on Assets | 3.81% |
| Revenue/Share (TTM) | $4.00 |
| Book Value | $6.62 |
| Price-to-Book | 2.25 |
| Price-to-Sales (TTM) | 3.80 |
| EV/Revenue | 3.225 |
| EV/EBITDA | 15.68 |
| Quarterly Earnings Growth (YoY) | 46.70% |
| Quarterly Revenue Growth (YoY) | 8.30% |
| Shares Outstanding | $20.21M |
| Float | $16.70M |
| % Insiders | 17.26% |
| % Institutions | 83.52% |
Historical Volatility
HV 10-Day
57.48%
HV 20-Day
55.81%
HV 30-Day
49.89%
HV 60-Day
47.51%
HV Rank
39.7%
Volatility is currently expanding
Analyst Ratings
Consensus ($23.67 target)
3
Buy4
HoldMore HEALTHCARE Stocks
Data last updated: 5/5/2026